Published in Prostate on January 01, 2004
Novel aspects of corneal angiogenic and lymphangiogenic privilege. Prog Retin Eye Res (2010) 1.33
Molecular profiling of cervical cancer progression. Br J Cancer (2007) 1.07
Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Neoplasia (2007) 1.04
Membrane type-1 matrix metalloproteinase potentiates basic fibroblast growth factor-induced corneal neovascularization. Am J Pathol (2009) 1.03
Targeting fibroblast growth factor pathways in prostate cancer. Clin Cancer Res (2013) 0.98
Endovascular laser–tissue interactions and biological responses in relation to endovenous laser therapy. Lasers Med Sci (2014) 0.96
MT1-MMP modulates bFGF-induced VEGF-A expression in corneal fibroblasts. Protein Pept Lett (2012) 0.89
Matrix metalloproteinase-14 mediates a phenotypic shift in the airways to increase mucin production. Am J Respir Crit Care Med (2009) 0.89
Targeting apoptosis pathways in cancer with alantolactone and isoalantolactone. ScientificWorldJournal (2013) 0.87
Blocking Fibroblast Growth Factor receptor signaling inhibits tumor growth, lymphangiogenesis, and metastasis. PLoS One (2012) 0.82
Wound healing fibroblasts modulate corneal angiogenic privilege: interplay of basic fibroblast growth factor and matrix metalloproteinases in corneal angiogenesis. Jpn J Ophthalmol (2010) 0.81
Fibroblast growth factors, old kids on the new block. Semin Cell Dev Biol (2016) 0.78
Growth factor mediated signaling in pancreatic pathogenesis. Cancers (Basel) (2011) 0.76
Molecular underpinnings of corneal angiogenesis: advances over the past decade. Int J Ophthalmol (2016) 0.75
Identification of differentially expressed genes in pancreatic cancer cells using cDNA microarray. Cancer Res (2002) 2.55
A new rabbit monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2 status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility. Appl Immunohistochem Mol Morphol (2007) 2.15
Expression of mTOR signaling pathway markers in prostate cancer progression. Prostate (2006) 1.57
Expression of dominant negative c-jun inhibits ultraviolet B-induced squamous cell carcinoma number and size in an SKH-1 hairless mouse model. Mol Cancer Res (2003) 1.51
Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol (2007) 1.46
Quantitative, spatial resolution of the epigenetic field effect in prostate cancer. Prostate (2008) 1.46
UVA-mediated activation of signaling pathways involved in skin tumor promotion and progression. Semin Cancer Biol (2004) 1.43
RING protein Trim32 associated with skin carcinogenesis has anti-apoptotic and E3-ubiquitin ligase properties. Carcinogenesis (2003) 1.37
The role of alpha 6 integrin in prostate cancer migration and bone pain in a novel xenograft model. PLoS One (2008) 1.31
Raf and MEK protein kinases are direct molecular targets for the chemopreventive effect of quercetin, a major flavonol in red wine. Cancer Res (2008) 1.30
Myricetin suppresses UVB-induced skin cancer by targeting Fyn. Cancer Res (2008) 1.29
Membrane type-1-matrix metalloproteinase expressed by prostate carcinoma cells cleaves human laminin-5 beta3 chain and induces cell migration. Cancer Res (2003) 1.25
Phase II study of erlotinib in patients with locally advanced or metastatic papillary histology renal cell cancer: SWOG S0317. J Clin Oncol (2009) 1.21
Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res (2004) 1.16
Phase 3 clinical trial investigating the effect of selenium supplementation in men at high-risk for prostate cancer. Prostate (2012) 1.15
Integrin alpha6 cleavage: a novel modification to modulate cell migration. Exp Cell Res (2007) 1.14
Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer Biol Ther (2006) 1.14
Different phenotypes in human prostate cancer: alpha6 or alpha3 integrin in cell-extracellular adhesion sites. Neoplasia (2002) 1.13
Myricetin is a novel natural inhibitor of neoplastic cell transformation and MEK1. Carcinogenesis (2007) 1.11
SAG/ROC2 E3 ligase regulates skin carcinogenesis by stage-dependent targeting of c-Jun/AP1 and IkappaB-alpha/NF-kappaB. J Cell Biol (2007) 1.11
UVB irradiation regulates Cox-2 mRNA stability through AMPK and HuR in human keratinocytes. Mol Carcinog (2008) 1.10
Aurora-A over-expression in high-grade PIN lesions and prostate cancer. Prostate (2005) 1.06
The laminin binding integrin alpha6beta1 in prostate cancer perineural invasion. J Cell Physiol (2010) 1.06
Effect of aspirin, other NSAIDs, and statins on PSA and PSA velocity. Prostate (2010) 1.06
Nucleolin stabilizes Bcl-X L messenger RNA in response to UVA irradiation. Cancer Res (2008) 1.05
Angiogenesis and neovascularization associated with extracellular matrix-modified porous implants. J Biomed Mater Res (2002) 1.04
Membrane-type 1 matrix metalloproteinase is regulated by sp1 through the differential activation of AKT, JNK, and ERK pathways in human prostate tumor cells. Neoplasia (2007) 1.04
Novel mechanisms of sublethal oxidant toxicity: induction of premature senescence in human fibroblasts confers tumor promoter activity. Exp Cell Res (2003) 1.04
A dominant negative c-jun specifically blocks okadaic acid-induced skin tumor promotion. Cancer Res (2002) 1.03
Randomized, double-blind, placebo-controlled trial of polyphenon E in prostate cancer patients before prostatectomy: evaluation of potential chemopreventive activities. Cancer Prev Res (Phila) (2011) 1.02
Membrane type 1 matrix metalloprotease cleaves laminin-10 and promotes prostate cancer cell migration. Neoplasia (2005) 1.01
The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells. Cancer Lett (2006) 0.99
Overexpression of tumor vascular endothelial growth factor A may portend an increased likelihood of progression in a phase II trial of bevacizumab and erlotinib in resistant ovarian cancer. Clin Cancer Res (2010) 0.99
Retracted Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue. Proc Natl Acad Sci U S A (2004) 0.97
Cross-validation of murine UV signal transduction pathways in human skin. Photochem Photobiol (2008) 0.97
p38 MAP kinase plays a functional role in UVB-induced mouse skin carcinogenesis. Mol Carcinog (2011) 0.96
The role of PI 3-kinase in the UVB-induced expression of c-fos. Oncogene (2002) 0.96
Fibroblast growth factor-1 induced promatrilysin expression through the activation of extracellular-regulated kinases and STAT3. Neoplasia (2002) 0.95
Inhibitory effects of sodium salicylate and acetylsalicylic acid on UVB-induced mouse skin carcinogenesis. Cancer Epidemiol Biomarkers Prev (2002) 0.93
Sunlight UV-induced skin cancer relies upon activation of the p38α signaling pathway. Cancer Res (2013) 0.93
Transcriptional repression of catalase in mouse skin tumor progression. Neoplasia (2004) 0.92
90K/Mac-2 binding protein is expressed in prostate cancer and induces promatrilysin expression. Prostate (2006) 0.91
7,3',4'-Trihydroxyisoflavone, a metabolite of the soy isoflavone daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4. J Biol Chem (2011) 0.90
Carbazole is a naturally occurring inhibitor of angiogenesis and inflammation isolated from antipsoriatic coal tar. J Invest Dermatol (2006) 0.88
Conjugated linoleic acid attenuates cyclooxygenase-2 transcriptional activity via an anti-AP-1 mechanism in MCF-7 breast cancer cells. J Nutr (2006) 0.88
Elevated basal reactive oxygen species and phospho-Akt in murine keratinocytes resistant to ultraviolet B-induced apoptosis. Mol Carcinog (2003) 0.88
Laminin alpha-1, alpha-3, and alpha-5 chain expression in human prepubertal [correction of prepubetal] benign prostate glands and adult benign and malignant prostate glands. Prostate (2003) 0.87
Involvement of oxidants and AP-1 in angiotensin II-activated NFAT3 transcription factor. Am J Physiol Cell Physiol (2006) 0.84
Stabilization of quercetin paradoxically reduces its proapoptotic effect on UVB-irradiated human keratinocytes. Cancer Prev Res (Phila) (2008) 0.84
Human laminin-5 and laminin-10 mediated gene expression of prostate carcinoma cells. Prostate (2006) 0.83
Stimulated endothelial cell adhesion and angiogenesis with laminin-5 modification of expanded polytetrafluoroethylene. Tissue Eng (2005) 0.83
Design and activity of a murine and humanized anti-CEACAM6 single-chain variable fragment in the treatment of pancreatic cancer. Cancer Res (2009) 0.83
Serum protein acidic and rich in cysteine (SPARC) as a prognostic marker in soft tissue sarcomas. Clin Sarcoma Res (2014) 0.82
Human Cell Surface Receptors as Molecular Imaging Candidates for Metastatic Prostate Cancer. Open Prost Cancer J (2009) 0.82
Catalase reverses tumorigenicity in a malignant cell line by an epidermal growth factor receptor pathway. Free Radic Biol Med (2005) 0.82
Mechanism of action of a dominant negative c-jun mutant in inhibiting activator protein-1 activation. Mol Carcinog (2002) 0.82
Molecular mechanism(s) for UV-B irradiation-induced glutathione depletion in cultured human keratinocytes. Photochem Photobiol (2004) 0.81
Differential localization of MT1-MMP in human prostate cancer tissue: role of IGF-1R in MT1-MMP expression. Prostate (2008) 0.81
ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma. Toxicol Sci (2011) 0.81
Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev (2004) 0.81
Activation of p38 MAP kinase and JNK pathways by UVA irradiation. Photochem Photobiol Sci (2011) 0.81
Targeting Bcl-X(L) for prevention and therapy of skin cancer. Mol Carcinog (2007) 0.80
Quercetin potentiates UVB-Induced c-Fos expression: implications for its use as a chemopreventive agent. Cancer Prev Res (Phila) (2010) 0.80
Sympathetic nerves in the tarsal tunnel: implications for blood flow in the diabetic foot. Plast Reconstr Surg (2008) 0.78
Involvement of mitogen-activated protein kinases and protein kinase C in regulation of antioxidant response element activity in human keratinocytes. Cancer Lett (2006) 0.78
Pharmacological inhibition of FGF receptor signaling inhibits LNCaP prostate tumor growth, promatrilysin, and PSA expression. Mol Carcinog (2003) 0.78
Nordihydroguaiaretic acid-mediated inhibition of ultraviolet B-induced activator protein-1 activation in human keratinocytes. Mol Carcinog (2002) 0.78
Integrin A6 Cleavage in Mouse Skin Tumors. Open Cancer J (2008) 0.77
Association of obesity and smoking with PSA and PSA velocity in men with prostate cancer. Am J Mens Health (2011) 0.77
Quercetin-3-methyl ether suppresses proliferation of mouse epidermal JB6 P+ cells by targeting ERKs. Carcinogenesis (2011) 0.77
Consensual interpretive guidelines for diagnostic immunohistochemistry. Am J Surg Pathol (2002) 0.77
Immunohistochemical comparison of vascular and sinusoidal adherens junctions in cavernosal endothelium. Urology (2004) 0.77
Determination of Optimum Formalin Fixation Duration for Prostate Needle Biopsies for Immunohistochemistry and Quantum Dot FISH Analysis. Appl Immunohistochem Mol Morphol (2015) 0.76
Androgens block interleukin-1 beta-induced promatrilysin expression in prostate carcinoma cells. Prostate (2002) 0.75
Automated brightfield dual-color in situ hybridization for detection of mouse double minute 2 gene amplification in sarcomas. Appl Immunohistochem Mol Morphol (2011) 0.75
Bioactivity and prostate tissue distribution of metformin in a preprostatectomy prostate cancer cohort. Eur J Cancer Prev (2017) 0.75
Mutations in the G-quadruplex silencer element and their relationship to c-MYC overexpression, NM23 repression, and therapeutic rescue. Proc Natl Acad Sci U S A (2005) 0.75